← Back to Search
Impact Of Nanotechnology On Drug Delivery.
O. Farokhzad, R. Langer
Published 2009 · Medicine, Materials Science
Download PDFAnalyze on Scholarcy
Nanotechnology is the engineering and manufacturing of materials at the atomic and molecular scale. In its strictest definition from the National Nanotechnology Initiative, nanotechnology refers to structures roughly in the 1-100 nm size regime in at least one dimension. Despite this size restriction, nanotechnology commonly refers to structures that are up to several hundred nanometers in size and that are developed by top-down or bottom-up engineering of individual components. Herein, we focus on the application of nanotechnology to drug delivery and highlight several areas of opportunity where current and emerging nanotechnologies could enable entirely novel classes of therapeutics.
This paper references
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles
S. Pun (2004)
Small-scale systems for in vivo drug delivery
David A. LaVan (2003)
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
The 'right' size in nanobiotechnology
G. Whitesides (2003)
Polymers for the sustained release of proteins and other macromolecules
R. Langer (1976)
Large unilamellar liposomes with low uptake into the reticuloendothelial system
T. Allen (1987)
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery.
Y. Patil (2009)
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
A. Klibanov (1990)
Drug delivery and targeting.
R. Langer (1998)
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
Travis A. Pecorelli (2010)
Nanoparticle–aptamer bioconjugates for cancer targeting
O. Farokhzad (2006)
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
F. Gu (2008)
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
S. T. Reddy (2007)
Hydrogen-bonding layer-by-layer-assembled biodegradable polymeric micelles as drug delivery vehicles from surfaces.
Byeong-Su Kim (2008)
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.
M. Dreher (2006)
Does a targeting ligand influence nanoparticle tumor localization or uptake?
K. Pirollo (2008)
PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.
N. Zhang (2008)
pH-sensitive liposomes: possible clinical implications.
M. Yatvin (1980)
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
P. Decuzzi (2008)
New methods of drug delivery.
R. Langer (1990)
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
By the right.
L. Robert (1988)
Delivery of molecular and cellular medicine to solid tumors.
R. Jain (2012)
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
Antibody Targeting of Liposomes : Cell Specificity Obtained by Conjugation of F ( ab ' ) 2 to Vesicle Surface
A. Ziegler (2011)
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles.
Ayush Verma (2008)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
D. Kirpotin (2006)
Inducible RNA interference-mediated gene silencing using nanostructured gene delivery arrays.
D. G. Mann (2008)
Pharmaceutical patent challenges — time for reassessment?
G. Glass (2004)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
Antitumor activity of an epithelial cell adhesion molecule–targeted nanovesicular drug delivery system
Sajid. Hussain (2007)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
The emerging nanomedicine landscape
Volker Wagner (2006)
Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A
L. Leserman (1980)
This paper is referenced by
The Influence of Viscosity on the Static and Dynamic Properties of PS-PEO Covered Emulsion Drops
Damith P Rozairo (2016)
Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs.
V. Jain (2014)
Simultaneous size and color tuning of polymer microparticles in a single-step microfluidic synthesis: particles for fluorescence labeling
Nikunjkumar Visaveliya (2015)
The Future of Glass-ionomers
Joshua James Cheetham (2016)
Transport and retention of silver nanoparticles in granular media filtration
Ijung Kim (2014)
Release of quercetin from micellar nanoparticles with saturated and unsaturated core forming polyesters--a combined computational and experimental study.
Salman Hassanzadeh (2015)
Nanoparticles prepared from the water extract of Gusuibu (Drynaria fortunei J. Sm.) protects osteoblasts against insults and promotes cell maturation
Chung-King Hsu (2011)
Porous Silicon Nanoparticles
Hélder A. Santos (2013)
Engineered RNA Nanodesigns for Applications in RNA Nanotechnology
Kirill A Afonin (2013)
A self-deploying drug release device using polymeric films.
Taro Kondo (2018)
Characterization of Calcined Jade and its immunomodulatory effect on macrophage isolated from Swiss albino mice
Asif Elahi (2017)
Colon-Targeted Drug Delivery Microparticles Prepared Using Electrohydrodynamic Atomization
D. Yu (2011)
Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics.
Fabiana de Sousa Cunha (2019)
Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways.
Lizhen He (2015)
Synthetic high-density lipoprotein-like nanoparticles for cancer therapy
L. Foit (2015)
Preparation and physicochemical characterization of naproxen-PLGA nanoparticles.
Y. Javadzadeh (2010)
Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy.
M. Lobatto (2015)
Gold Nanocage-Based Dual Responsive "Caged Metal Chelator" Release System: Noninvasive Remote Control with Near Infrared for Potential Treatment of Alzheimer's Disease
Peng Shi (2013)
Nanoparticles with high payloads of pipemidic acid, a poorly soluble crystalline drug: drug-initiated polymerization and self-assembly approach
Elisabetta Pancani (2018)
Barminomycin, a model for the development of new anthracyclines.
K. Kimura (2010)
Nano Fabricated 3D Extracellular Matrix (ECM) Scaffolds to alter the Cancer Cell Behavior
G. Punchihewa (2012)
Solvent selection causes remarkable shifts of the "Ouzo region" for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation.
M. Beck-Broichsitter (2015)
Metalloporphyrin Complex-Based Nanosonosensitizers for Deep-Tissue Tumor Theranostics by Noninvasive Sonodynamic Therapy.
A. Ma (2019)
Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.
C. de la Torre (2014)
Nanodiamondsasvehiclesfor systemicandlocalizeddrug delivery
R. Lam (2009)
Modeling and experiments of magneto-nanosensors for diagnostics of radiation exposure and cancer
Dokyoon Kim (2013)
Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging
R. Lu (2013)
Fabrication of 3-Dimensional Polymeric Drug Delivery Systems
Y. Chen (2017)
Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics.
S. Goel (2014)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
Noninvasive optical imaging of nanomedicine biodistribution.
S. Kunjachan (2013)
Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm
Melissa D. Howard (2014)See more